Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
WalgreensWBA |
-$59,000 |
 |
CVS HealthCVS |
-$110,000 |
 |
Home DepotHD |
$99,000 |
 |
Lowe'sLOW |
-$64,000 |
 |
CostcoCOST |
-$150,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ro Khanna | Oct 24, 2025 | Sell | $1K - $15K |
| Dan Newhouse | Aug 18, 2025 | Buy | $1K - $15K |
| Ro Khanna | Jul 25, 2025 | Buy | $1K - $15K |
| Ro Khanna | Jul 8, 2025 | Sell | $1K - $15K |
| Rob Bresnahan | Apr 8, 2025 | Sell | $1K - $15K |
| Kelly Morrison | Mar 21, 2025 | Sell | $100K - $250K |
| Jefferson Shreve | Mar 5, 2025 | Buy | $15K - $50K |
| Kelly Morrison | Mar 3, 2025 | Buy | $1K - $15K |
| Valerie Hoyle | Feb 4, 2025 | Buy | $1K - $15K |
| Earl Blumenauer | Sep 26, 2024 | Buy | $15K - $50K |
| Rohit Khanna Democrat | May 22, 2024 | Buy | $1K - $15K |
| Rohit Khanna Democrat | May 22, 2024 | Buy | $1K - $15K |
| Thomas Carper Democrat | May 22, 2024 | Buy | $1K - $15K |
| Thomas Carper Democrat | Feb 16, 2024 | Buy | $1K - $15K |
FAQ - Congress Trading
Ro Khanna sold Target shares most recently on October 24, 2025.
Earl Blumenauer has bought the most TGT stock in the last 2 years, with an estimated value of $33,000.
Kelly Morrison has sold the most TGT stock in the last 2 years, with an estimated value of $180,000.
The net value of trades by US politicians for Target in the last 2 years is negative, amounting to -$69,000. This suggests that US politicians do not believe in the success of the company for various reasons.
Over the last 2 years, insider transactions for Target have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
